3 Magnificent Growth Stocks to Buy in July

The article highlights AI-driven growth catalysts across Axon, Dutch Bros, and MercadoLibre, citing strong early results: Axon Q1 revenue +34% y/y and SaaS revenue +35% with net revenue retention of 125% (EPS $1.61 vs $1.47 last year). Dutch Bros Q1 sales +31% y/y and same-store sales +8.4%, with adjusted EBITDA up 26% to $79.4M. MercadoLibre Q1 revenue +49% y/y, GMV +42%, and total payment volume +50% as AI/data initiatives support expansion in underpenetrated LatAm e-commerce and fintech.

Analysis

The cleaner signal here is not “AI is hot” but that AI is migrating from infrastructure into workflow monetization. AXON and MELI have that profile: software/data attach rates and high retention create operating leverage that can support multiple expansion even if headline growth slows a bit. That makes them more durable than pure narrative names because the equity case is tied to recurring monetization, not just capex cycles.

BROS is the most fragile of the three from a valuation mechanics standpoint. Store growth can look great until unit-level traffic or ticket growth normalizes, and then the market tends to re-rate aggressively because the franchise is still proving long-duration demand. The second-order loser is SBUX: not because BROS is a direct existential threat, but because the faster-growing cold/customized beverage niche can keep siphoning younger traffic and pricing power if macro pressure pushes consumers to trade down within the category.

Contrarianly, the geopolitics framing around AXON is probably overfitted; the real driver is budgeted software adoption by public safety agencies, which is a months-to-years rerating story rather than a days-long event trade. For MELI, Aug. 5 is the key catalyst window: if profitability and credit quality hold while growth remains above 40% GMV/TPV, the stock can claw back the year-to-date drawdown quickly. Falsifiers: AXON NRR slipping below ~120%, BROS comp growth dropping to low single digits, or MELI showing credit/profitability slippage in Brazil/Mexico.

Key Decisions for Investors

• Buy MELI into the Aug. 5 print via a staggered entry or call spread; the setup is 1-3 month upside if margins hold, with 15-20% upside potential on a clean beat and raise.
• Own AXON on a pullback rather than chase strength; treat it as a 6-12 month compounder. Invalidate if SaaS retention trends toward <120% or margins roll over.
• Avoid initiating a fresh long in BROS at current levels; wait for either a 10-15% drawdown or proof that same-store sales stay mid/high-single-digit after expansion. High execution risk, lower margin of safety.
• Tactical pair: long BROS / short SBUX only if consumer trade-down data stays supportive and BROS keeps outperforming on comps; otherwise the cleaner relative-value trade is to stay flat.
• No direct trade in NVDA/NDAQ from this note; the better expression of AI breadth is to own application-layer beneficiaries like AXON and MELI instead of paying up for the obvious semiconductor beta.